Register entry
SciAnda (Changshu) Pharmaceuticals, Ltd.
Data as of · How to read this entry
- Registered sites
- 1
- Active NDC listings
- 16
- Labeller names
- 2
- Live patents
- 0
- Countries
- 1
- Base
- China
Authorisation
Registered operations
Active ingredient (API) manufacture1Finished drug manufacture1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| SciAnda (Changshu) Pharmaceuticals, Ltd. | No. 16, DongZhou Road, Economic Development Zone, Changshu, Jiangsu 215513, China (CHN) | Active ingredient (API) manufacture, Finished drug manufacture | 3009853264421270300 |
Catalogue
Drug listings by form and route
1616 active NDC listings: 16 bulk ingredient. By marketing category: BULK INGREDIENT 16.
| Dosage form | NDCs |
|---|---|
| powder | 16 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| scianda(changshu) pharmaceuticals, ltd. | 10 |
| scianda (changshu) pharmaceuticals, ltd. | 6 |
Catalogue
Marketed products
16| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Abemaciclib | powder | 54245-1495BULK INGREDIENT |
| - | Alpelisib | powder | 54245-1462BULK INGREDIENT |
| - | Atazanavir Sulfate | powder | 54245-7031BULK INGREDIENT |
| - | Bimatoprost | powder | 54245-7036BULK INGREDIENT |
| - | Bortezomib | powder | 54245-7004BULK INGREDIENT |
| - | Capecitabine | powder | 54245-7014BULK INGREDIENT |
| - | Celecoxib | powder | 54245-3392BULK INGREDIENT |
| - | Decitabine | powder | 54245-7035BULK INGREDIENT |
| - | Eflornithine Hydrochloride | powder | 54245-3110BULK INGREDIENT |
| - | Gefitinib | powder | 54245-1359BULK INGREDIENT |
| - | Gemcitabine Hydrochloride | powder | 54245-1091BULK INGREDIENT |
| - | Lapatinib Ditosylate | powder | 54245-7005BULK INGREDIENT |
| - | Olaparib | powder | 54245-1464BULK INGREDIENT |
| - | Osimertinib Mesylate | powder | 54245-1451BULK INGREDIENT |
| - | Roflumilast | powder | 54245-7016BULK INGREDIENT |
| - | TOPIRAMATE | powder | 54245-1024BULK INGREDIENT |
Compare
Comparable companies in China
- Kingkey MBC Life Technology Group co., LTD.1 site · 158 NDC
- Qingdao Biopeptek Co Ltd1 site · 110 NDC
- Zhejiang Guoyao Jingyue Aerosol Co Ltd1 site · 94 NDC
- Shenzhen iShan Technology Co Ltd1 site · 84 NDC
- Xiamen Kang Zhongyuan Biotechnology Co., Ltd.1 site · 68 NDC
- Changzhou Maokang Medical Products Co., Ltd1 site · 59 NDC
- Jianerkang Medical Co Ltd1 site · 56 NDC
- Zhejiang Ausun Pharmaceutical Co., Ltd.1 site · 55 NDC
- Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd1 site · 40 NDC
- Guangdong Aimu Biological Technology Co Ltd1 site · 39 NDC
Enquiry
Common questions
- Is SciAnda (Changshu) Pharmaceuticals, Ltd. FDA approved?
- SciAnda (Changshu) Pharmaceuticals, Ltd. holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are SciAnda (Changshu) Pharmaceuticals, Ltd.'s drugs manufactured?
- The FDA register lists Changshu. Registered operations: active ingredient (API) manufacture, finished drug manufacture.
- What drugs does SciAnda (Changshu) Pharmaceuticals, Ltd. make?
- 16 products are listed under SciAnda (Changshu) Pharmaceuticals, Ltd. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.